When did Merck announce the completion of its acquisition of JSR Life Sciences' chromatography business?

Merck announced the completion of its acquisition of JSR Life Sciences' chromatography business in 2025, following an agreement announced in October 2025.

What specific technology and product does Merck gain from acquiring JSR Life Sciences' chromatography business?

Merck gains the Amsphere™ Protein A resin and advanced Protein A chromatography technology from the acquisition of JSR Life Sciences' chromatography business.

How will the acquired chromatography business be integrated within Merck's operations?

The acquired chromatography business will be integrated into Merck's Process Solutions portfolio to support biopharmaceutical manufacturing from development to full-scale production.

How many employees from JSR Life Sciences' chromatography unit will join Merck after the acquisition?

More than 50 employees from the Belgium-based chromatography unit of JSR Life Sciences will join Merck following the acquisition.

What benefit does Merck expect to provide to its customers through this acquisition?

Merck expects to improve customer productivity and enable reliable large-scale manufacturing of monoclonal antibodies by expanding its Protein A solutions and downstream purification technologies.

AI News NQ Analysis

Merck Completes Acquisition of JSR Life Sciences' Chromatography Business, Strengthening Protein A Technology and Expanding Downstream Portfolio

NQ Score 100/100

AI Summary (NQ-processed)

Merck has completed the acquisition of JSR Life Sciences' chromatography business, integrating advanced Protein A technology and Amsphere™ Protein A resins into its downstream process portfolio. This acquisition strengthens Merck's ability to support the efficient and scalable purification of monoclonal antibodies, helping customers improve productivity and accelerate access to critical therapeutics. Over 50 employees from the acquired Belgian chromatography unit will join Merck, enhancing its global technical support and application expertise in biopharmaceutical manufacturing.

AI analysis data is not yet available.

Frequently Asked Questions

Q: When did Merck announce the completion of its acquisition of JSR Life Sciences' chromatography business?: A: Merck announced the completion of its acquisition of JSR Life Sciences' chromatography business in 2025, following an agreement announced in October 2025.
Q: What specific technology and product does Merck gain from acquiring JSR Life Sciences' chromatography business?: A: Merck gains the Amsphere™ Protein A resin and advanced Protein A chromatography technology from the acquisition of JSR Life Sciences' chromatography business.
Q: How will the acquired chromatography business be integrated within Merck's operations?: A: The acquired chromatography business will be integrated into Merck's Process Solutions portfolio to support biopharmaceutical manufacturing from development to full-scale production.
Q: How many employees from JSR Life Sciences' chromatography unit will join Merck after the acquisition?: A: More than 50 employees from the Belgium-based chromatography unit of JSR Life Sciences will join Merck following the acquisition.
Q: What benefit does Merck expect to provide to its customers through this acquisition?: A: Merck expects to improve customer productivity and enable reliable large-scale manufacturing of monoclonal antibodies by expanding its Protein A solutions and downstream purification technologies.